Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edwards Lifesciences (EW)
NYSE:EW
Edwards Lifesciences (EW) Ownership - Who Owns Edwards Lifesciences?
1,644 Followers
Edwards Lifesciences (EW) Ownership Overview
1.06% Insiders
22.27% Mutual Funds
21.51% Other Institutional Investors
55.16% Public Companies and Individual Investors
The ownership structure of Edwards Lifesciences (EW) stock is a mix of institutional, retail and individual investors. Approximately 43.78% of the company’s stock is owned by Institutional Investors, 1.06% is owned by Insiders and 55.16% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 26, 2024 | Kieran Gallahue Director | Bought | $260084 |
| Feb 26, 2024 | Kieran Gallahue Director | Sold | $267911 |
| Feb 21, 2024 | Daveen Chopra Cvp, Tmtt | Sold | $711254 |
| Feb 15, 2024 | Catherine Szyman Cvp, Critical Care | Sold | $4040670 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $17385 | |
| Dec 31, 2023 | Sold | $49181 | |
| Dec 31, 2023 | Bought | $85247 | |
| Dec 31, 2023 | Sold | $226996 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 46,843,806 | Institution | 7.79% | 4,025,756,688 | |
| 40,106,001 | Institution | 6.67% | 3,446,709,726 | |
| 30,495,713 | Institution | 5.07% | 2,620,801,575 | |
| 20,968,928 | Institution | 3.49% | 1,802,069,672 | |
| 9,842,255 | Institution | 1.64% | 845,843,395 | |
| 9,397,740 | Institution | 1.56% | 807,641,776 | |
| 7,133,892 | Institution | 1.19% | 613,086,678 | |
| 6,103,702 | Institution | 1.02% | 524,552,150 | |
| 4,557,473 | Institution | 0.76% | 391,669,230 | |
| 4,420,409 | Institution | 0.74% | 379,889,949 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 40,106,001 | Institution | 6.67% | 3,446,709,726 | |
| 9,842,255 | Institution | 1.64% | 845,843,395 | |
| 9,397,740 | Institution | 1.56% | 807,641,776 | |
| 4,557,473 | Institution | 0.76% | 391,669,230 | |
| 4,420,409 | Institution | 0.74% | 379,889,949 | |
| 3,956,364 | Institution | 0.66% | 340,009,922 | |
| 3,426,052 | Institution | 0.57% | 294,434,909 | |
| 3,094,000 | Institution | 0.51% | 265,898,360 | |
| 2,778,147 | Institution | 0.46% | 238,753,953 | |
| 2,690,213 | Institution | 0.45% | 231,196,905 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 18,938,721 | Institution | 3.15% | 1,809,784,179 | |
| 15,286,538 | Institution | 2.54% | 1,460,781,571 | |
| 7,266,275 | Institution | 1.21% | 631,875,274 | |
| 7,186,715 | Institution | 1.20% | 617,626,287 | |
| 5,708,280 | Institution | 0.95% | 545,483,237 | |
| 6,219,238 | Institution | 1.03% | 540,824,936 | |
| 4,447,292 | Institution | 0.74% | 382,200,274 | |
| 2,813,350 | Institution | 0.47% | 244,648,916 | |
| 2,066,228 | Institution | 0.34% | 197,448,748 | |
| 2,040,891 | Institution | 0.34% | 177,475,881 |
FAQ
Who Owns Edwards Lifesciences (EW)?
According to the latest TipRanks data, approximately 21.51% of the company's stock is held by institutional investors, 1.06% is held by insiders, and 55.16% is held by retail investors.
What percentage of Edwards Lifesciences (EW) stock is held by institutional investors?
According to the latest TipRanks data, approximately 21.51% of Edwards Lifesciences (EW) stock is held by institutional investors.
What percentage of Edwards Lifesciences (EW) stock is held by retail investors?
According to the latest TipRanks data, approximately 55.16% of Edwards Lifesciences (EW) stock is held by retail investors.
Who owns the most shares of Edwards Lifesciences (EW)?
Vanguard owns the most shares of Edwards Lifesciences (EW).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.